Patents by Inventor Alan Chow
Alan Chow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11927611Abstract: A system includes a sensor configured at a first position to sense an orientation of an electricity meter. The electricity meter can be configured at a second position. The electricity meter can be configured at a normal orientation to measure delivered energy sent to one or more locations and received energy received from the one or more locations. The electricity meter can be configured at an inverted orientation to identify and measure the delivered energy sent to the one or more locations and the received energy received from the one or more locations. The sensor is configured to identify when the electricity meter is in the normal orientation, and when the electricity meter is in the inverted orientation. A display is configured within the electricity meter.Type: GrantFiled: May 3, 2021Date of Patent: March 12, 2024Assignee: HONEYWELL INTERNATIONAL INC.Inventors: Mark Alan Ranta, Dacon Thomas Chow, Michael Anthony Murphy, William Egolf
-
Patent number: 7812179Abstract: A process is provided for preparing (R)-5-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-5-hydroxy-3-oxo-1-heptanoic acid, R-substituted ester 9 comprising: (a) reacting the aldehyde 1 with the enolate form of (S)-2-hydroxy-1,2,2-triphenylethyl acetate substituent in a chelating co-solvent; (b) hydrolysis of (R,S)-5-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3-hydroxy-1-pentanoic acid, (S)-2-hydroxy-1,2,2-triphenylethyl ester (2a and 2b) using a base, preferably an alkali metal base, preferably in a solvent to form the carboxylic acid 7; (c) treating the acid 7 with a chiral base to form a salt and purifying the salt to obtain enantiomerically enriched (R)-7 chiral base salt; (d) alkylation of the (R)-7 chiral base salt or the free base derived from (R)-7, forming (R)-5-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-5-hydroxy-3-oxo-1-heptanoic acid,Type: GrantFiled: August 14, 2008Date of Patent: October 12, 2010Assignee: Apotex PharmaChem Inc.Inventors: Fan Wang, Daqing Che, Bhaskar Reddy Guntoori, Yajun Zhao, Aaron C. Kinsman, Jody Faught, Alan Chow
-
Publication number: 20090131683Abstract: A process is provided for preparing (R)-5-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-5-hydroxy-3-oxo-1-heptanoic acid, R-substituted ester 9 comprising: (a) reacting the aldehyde 1 with the enolate form of (S)-2-hydroxy-1,2,2-triphenylethyl acetate substituent in a chelating co-solvent; (b) hydrolysis of (R,S)-5-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3-hydroxy-1-pentanoic acid, (S)-2-hydroxy-1,2,2-triphenylethyl ester (2a and 2b) using a base, preferably an alkali metal base, preferably in a solvent to form the carboxylic acid 7; (c) treating the acid 7 with a chiral base to form a salt and purifying the salt to obtain enantiomerically enriched (R)-7 chiral base salt; (d) alkylation of the (R)-7 chiral base salt or the free base derived from (R)-7, forming (R)-5-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-5-hydroxy-3-oxo-1-heptanoic acid,Type: ApplicationFiled: August 14, 2008Publication date: May 21, 2009Inventors: Fan Wang, Daqing Che, Bhaskar Reddy Guntoori, Yajun Zhao, Aaron C. Kinsman, Jody Faught, Alan Chow
-
Patent number: 7429613Abstract: A process is provided for preparing (R)-5-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-5-hydroxy-3-oxo-1-heptanoic acid, R-substituted ester 9 comprising: (a) reacting the aldehyde 1 with the enolate form of (S)-2-hydroxy-1,2,2-triphenylethyl acetate substituent in a chelating co-solvent; (b) hydrolysis of (R,S)-5-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3-hydroxy-1-pentanoic acid, (S)-2-hydroxy-1,2,2-triphenylethyl ester (2a and 2b) using a base, preferably an alkali metal base, preferably in a solvent to form the carboxylic acid 7; (c) treating the acid 7 with a chiral base to form a salt and purifying the salt to obtain enantiomerically enriched (R)-7 chiral base salt; (d) alkylation of the (R)-7 chiral base salt or the free base derived from (R)-7, forming (R)-5-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-5-hydroxy-3-oxo-1-heptanoic acid,Type: GrantFiled: July 17, 2006Date of Patent: September 30, 2008Assignee: Apotex Pharmachem Inc.Inventors: Fan Wang, Daqing Che, Bhaskar Reddy Guntoori, Yajun Zhao, Aaron C. Kinsman, Jody Faught, Alan Chow
-
Publication number: 20060252816Abstract: A process is provided for preparing (R)-5-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-5-hydroxy-3-oxo-1-heptanoic acid, R-substituted ester 9 comprising: (a) reacting the aldehyde 1 with the enolate form of (S)-2-hydroxy-1,2,2-triphenylethyl acetate substituent in a chelating co-solvent; (b) hydrolysis of (R,S)-5-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3-hydroxy-1-pentanoic acid, (S)-2-hydroxy-1,2,2-triphenylethyl ester (2a and 2b) using a base, preferably an alkali metal base, preferably in a solvent to form the carboxylic acid 7; (c) treating the acid 7 with a chiral base to form a salt and purifying the salt to obtain enantiomerically enriched (R)-7 chiral base salt; (d) alkylation of the (R)-7 chiral base salt or the free base derived from (R)-7, forming (R)-5-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-5-hydroxy-3-oxo-1-heptanoic acid, R-substituted esterType: ApplicationFiled: July 17, 2006Publication date: November 9, 2006Inventors: Fan Wang, Daqing Che, Bhaskar Guntoori, Yajun Zhao, Aaron Kinsman, Jody Faught, Alan Chow
-
Patent number: 7112604Abstract: A process is provided for preparing (R)-5-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-5-hydroxy-3-oxo-1-heptanoic acid, R-substituted ester 9 comprising: (a) reacting the aldehyde 1 with the enolate form of (S)-2-hydroxy-1,2,2-triphenylethyl acetate substituent in a chelating co-solvent; (b) hydrolysis of (R,S)-5-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3-hydroxy-1-pentanoic acid, (S)-2-hydroxy-1,2,2-triphenylethyl ester (2a and 2b) using a base, preferably an alkali metal base, preferably in a solvent to form the carboxylic acid 7; (c) treating the acid 7 with a chiral base to form a salt and purifying the salt to obtain enantiomerically enriched (R)-7 chiral base salt; (d) alkylation of the (R)-7 chiral base salt or the free base derived from (R)-7, forming (R)-5-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-5-hydroxy-3-oxo-1-heptanoic acid,Type: GrantFiled: April 6, 2005Date of Patent: September 26, 2006Assignee: Apotex Pharmachem Inc.Inventors: Fan Wang, Daqing Che, Bhaskar Reddy Guntoori, Yajun Zhao, Aaron C. Kinsman, Jody Faught, Alan Chow
-
Publication number: 20060194867Abstract: A process is provided for preparing (R)-5-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-5-hydroxy-3-oxo-1-heptanoic acid, R-substituted ester 9 comprising: (a) reacting the aldehyde 1 with the enolate form of (S)-2-hydroxy-1,2,2-triphenylethyl acetate substituent in a chelating co-solvent; (b) hydrolysis of (R,S)-5-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3-hydroxy-1-pentanoic acid, (S)-2-hydroxy-1,2,2-triphenylethyl ester (2a and 2b) using a base, preferably an alkali metal base, preferably in a solvent to form the carboxylic acid 7; (c) treating the acid 7 with a chiral base to form a salt and purifying the salt to obtain enantiomerically enriched (R)-7 chiral base salt; (d) alkylation of the (R)-7 chiral base salt or the free base derived from (R)-7, forming (R)-5-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-5-hydroxy-3-oxo-1-heptanoic acid, R-substituted esterType: ApplicationFiled: April 6, 2005Publication date: August 31, 2006Inventors: Fan Wang, Daqing Che, Bhaskar Guntoori, Yajun Zhao, Aaron Kinsman, Jody Faught, Alan Chow
-
Publication number: 20060142818Abstract: Methods of using electrical stimulation by itself or in conjunction with growth factors to treat and prevent visual loss due to choroidal, retinal pigment epithelial and/or neuroretinal cell degeneration and dysfunction are presented.Type: ApplicationFiled: December 12, 2005Publication date: June 29, 2006Inventors: Alan Chow, Vincent Chow
-
Publication number: 20060142857Abstract: An artificial retinal device, implanted in the subretinal space of the eye in persons with certain types of retinal blindness, induces artificial vision by electrical stimulation of the remaining viable cells of the retina. The artificial retina device includes a stimulating electrode unit preferably placed in the subretinal space.Type: ApplicationFiled: December 2, 2005Publication date: June 29, 2006Inventors: Alan Chow, Vincent Chow
-
Patent number: 6907338Abstract: A method of controlling an injector or the like suitable for use in an internal combustion engine, includes providing a first data map having a plurality of first data map points, each of the first data map points representing a first data map output value, and providing a function map comprising a second data map having a plurality of second data map points, each corresponding to a respective one of the first data map points, and wherein the second data map is divided into at least a first-type data map region containing second data map points representing second data map output values only of a first type and a second-type data map region containing second data map points representing second data map output values only of a second type, wherein a portion of the second data map defines a hysteresis region.Type: GrantFiled: March 13, 2003Date of Patent: June 14, 2005Assignee: Delphi Technologies, Inc.Inventors: Jason Paul Frankl, Alan Chow, Vidya Shankar Somasundaram, Edward Thomas Williams
-
Publication number: 20050033202Abstract: Mechanically activated objects or devices for use in treating degenerative retinal diseases are provided. Such devices apply mechanical forces to tissues of an eye to effectuate treatment and are configured for chronic implantation (thereby applying chronic stimulation/irritation) in or on the eye. The devices may be configured for contact with a retina of the eye, preferably positioned in a subretinal space. Various embodiments comprise a moving member configured for chronic contact with at least a portion of the eye, which moving member is activated by an actuator. In some embodiments, the actuator may be distally located relative to the moving member. Alternatively, the moving member may be supported by a body member that, optionally, also supports the actuator.Type: ApplicationFiled: April 12, 2004Publication date: February 10, 2005Inventors: Alan Chow, George McLean, Vincent Chow, Jay Cech, Christopher Bonner, Vladimir Gelfandbein
-
Publication number: 20050004625Abstract: To provide indirect electrical stimulation for treatment of degenerative retinal diseases, such stimulation is applied to surface structures of the eye. A source of an electrical stimulation signal is coupled to a first electrode configured for contact with a first internal surface structure of an eyeball. A second electrode, which may be configured either for contact with an internal surface structure or an external surface structure of the eyeball, is also coupled to the source. The source of the electrical stimulation signal may be implemented internal to a body of a patient, external to the body or through a combined internal/external approach. The first and second electrodes are preferably arranged such that the circuit created by the source, electrodes and intervening biological tissue provides trans-retinal electrical stimulation to thereby effect treatment.Type: ApplicationFiled: June 9, 2004Publication date: January 6, 2005Inventor: Alan Chow
-
Publication number: 20040000294Abstract: A method of controlling an injector or the like suitable for use in an internal combustion engine, includes providing a first data map having a plurality of first data map points, each of the first data map points representing a first data map output value, and providing a function map comprising a second data map having a plurality of second data map points, each corresponding to a respective one of the first data map points, and wherein the second data map is divided into at least a first-type data map region containing second data map points representing second data map output values only of a first type and a second-type data map region containing second data map points representing second data map output values only of a second type, wherein a portion of the second data map defines a hysteresis region.Type: ApplicationFiled: March 13, 2003Publication date: January 1, 2004Inventors: Jason Paul Frankl, Alan Chow, Vidya Shankar Somasundaram, Edward Thomas Williams